Urinary incontinence and erectile dysfunction post radical prostatectomy (RP): results from self administered questionnaires in a national observational study (repair) by the French urological association (AFU)

101 th meeting American Urological Association May 19- 24 2007, Anaheim, USA

J Urol - 2007 : Apr; 177(4 Suppl)

Endothelial dysfunction and oxydative stress associated with the metabolic syndrome can be reversed by a chronic treatment with sildenafil

101 th meeting American Urological Association May 19- 24 2007, Anaheim, USA

J Urol - 2007 : Apr; 177(4 Suppl) - Oral presentation

Combination of alfuzosin and tadalafil exerts an additive relaxant effect on human prostate

International Continence Society meeting Rotterdam 2007

Neurourol Urodyn. - 2007 : 26, 5, P 717

Combination of alfuzosin and tadalafil exerts an additive relaxing effect on precontracted human corpus cavernosum

29th Congress of the Societé Internationale d’Urologie Sept 2-6, 2007, Paris

Urology - 2007 : 70, Suppl 3A, p104

Combination of alfuzosin and tadalafil exerts an additive relaxant effect on human prostate

29th Congress of the Societé Internationale d’Urologie Sept 2-6, 2007, Paris

Urology - 2007 : 70, Suppl 3A, p109

Combination of alfuzosin and tadalafil exerts an additive enhancing effect on norepinephrine-induced relaxation of pre-contracted human detrusor smooth muscle

29th Congress of the Societé Internationale d’Urologie Sept 2-6, 2007, Paris

Urology - 2007 : 70, Suppl 3A, p 154

Intravenous administration of 7-hydroxy-2-(di-N-propylamino)tetralin induces sexual responses in anaesthetized males rats

10th congress of the European Society for Sexual Medicine (ESSM) Lisbon Portugal – Nov 25-28, 2007.

J. Sex. Med. - 2007 : 5 (suppl 2),#MP-02-86

Daily treatment with sildenafil reverses endothelial dysfunction and oxidative stress in an animal model of metabolic syndrome.

3rd International cGMP Meeting: Generators and effectors (Dresde, Allemagne, Juin 2007) - poster

BMC Pharmacology - 2007 : 7 (Suppl 1)

Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses endothelial dysfunction and oxidative stress associated with the metabolic syndrome

3rd International cGMP Meeting: Generators and effectors (Dresde, Allemagne, Juin 2007) - Oral presentation

BMC Pharmacology - 2007 : 7(Suppl 1)

Melanotan II : investigation of the inducer and facilitator effect effects on penile erection in anaesthetized rat

Neuroscience - 2006 : 138(1):293-301

D2-like receptors mediate the expulsion phase of ejaculation elicited by 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in rats

J. Exp. Pharm. Therap. - 2006 : 316(2):830-4

Efficacy and safety of vardenafil in men with erectile dysfunction caused by spinal cord injury

Neurology - 2006 : 66:210–216

Identification of the lumbar spinal interneurons controlling both prostate and bulbospongiosus muscle simultaneous with two strains of recombinants pseudorabies virus in male rat

Neuroscience - 2006 : 138: 561-573

L6-S1 spinal nerves stimulation reduces micturition frequency in anesthetized rats with cyclophosphamide-induced cystitis

Brit. J. Urol. - 2006 : 97(2):386-92

Hemodynamic Interaction Study Between the Alpha1-Blocker Alfuzosin and the Phosphodiesterase 5 Inhibitor Tadalafil in Middle-Aged Healthy Male Subjects

Urology - 2006 : 67(6):1199-204

Role of peripheral innervation in p-chloroamphetamine (PCA)-induced ejaculation in anesthetized rats

J.Androl. - 2006 : 27(3):381-9

Effects of potassium channels modulators on human detrusor smooth muscle myogenic phasic contractile activity : potential therapeutic targets for overactive bladder

Urology - 2006 : 68(2):442-8

Effect of the 5-HT2A/2C receptor agonist DOI on female rat sexual behavior

J Sex Med - 2006 : 3:432–441

Evaluation of the Efficacy and Safety of Once-a-Day Dosing of Tadalafil 5 mg and 10 mg in the Treatment of Erectile Dysfunction: Results of a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

Eur. Urol. - 2006 : 50: 351–359

Erectile dysfunction in hypercholesterolemic atherosclerotic apolipoprotein E knockout mice

J. Sex. Med. - 2006 : 3:596–603